Market Research Logo

Dry Eye Syndrome Treatment Market Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027

Dry Eye Syndrome Treatment Market Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027

The global dry eye syndrome treatment market is estimated to be valued at nearly US$ 3,560 Mn by 2017 end, and is projected to reach about US$ 6,610 Mn by the end of 2027, registering a CAGR of 6.4% over the forecast period.

Development of newer delivery systems aiding market growth in the North America region

Candorvision launched the CALMO Eye Spray, which was the first preservative free eye spray to be launched in Canada. Eye spray improves the humidification of the eyelids and eyes and acts as a substitute for people who avoid eye drops. With its German liposome technology, CALMO Eye Spray repairs and stabilises the lipid layer of the tear film and thus effectively addresses one of the root causes of dry eye syndrome. Leading market players are trying to develop dry eye care products in different delivery systems so as to ensure better patient compliance and utilisation along with company profitability.

LASIK surgery becoming mainstream

More and more supplement manufacturers are creating products targeted specifically at dry eye. One reason for this is because LASIK surgery is becoming more mainstream, and almost everybody who has LASIK will also suffer from dry eye syndrome in the first six months after their treatment. At the same time however, not all the supplements that exist have proven benefits, and they certainly aren’t all created equally. It is also very important to understand that certain supplements counteract other types of medication. Hence, self-medication on supplements without first seeking medical advice is not recommended.

No price control stifling the market growth of dry eye syndrome treatment in United States

Most of the other countries have some form of price controls; the government negotiates with drug companies and device makers for lower prices, and the government has the power to win those negotiations. The United States doesn't do that. It leaves the negotiations up to individual insurers. Defenders of the American system argue that price controls stifle innovation. Many say that higher spending creates financial incentives for drug companies to come up with wonderful new drugs. But that means the U.S. population is paying higher prices to subsidise drugs for the rest of the world.

Global Dry Eye Syndrome Treatment Market Forecast, By Region

By the end of 2027, the dry eye syndrome treatment market in North America is anticipated to reach a market valuation in excess of US$ 2,500 Mn, exhibiting a CAGR of 6.7% over the forecast period. The North America dry eye syndrome treatment market is expected to represent an absolute $ opportunity of US$ 88.6 Mn in 2018 over 2017, also creating an incremental opportunity of US$ 1,207.4 Mn between 2017 and 2027.

By the end of 2027, the dry eye syndrome treatment market in APEJ is anticipated to reach US$ 878.7 Mn, registering a CAGR of 7.4% over the forecast period. The APEJ dry eye syndrome treatment market is expected to represent an absolute $ opportunity of US$ 29.7 Mn in 2018 over 2017, also creating an incremental opportunity of US$ 446.4 Mn between 2017 and 2027. Eye drops containing preservatives often have chances of causing some eye allergies and prolonged use may hamper the sight of an individual. The trend of using single dose preservative free eye drops has now created new opportunities especially in developed regions of the world. Such eye drops are considered as safe for prolonged usage as they are preservative free. Allergan recently launched their OPTIVE REFRESH product, which is single use preservative free lubricating eye drops. Biocia Inc. commercialised their viscoadaptive eye drop innovations in a preservative free delivery system. Viscoadaptive eye drops are lubricant eye drop solutions that exhibit both cohesive and dispersive behaviours depending on the shear energy in the solution.” --- Analyst – Healthcare, Pharmaceuticals and Medical Devices, Future Market Insights


1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Market Viewpoint
3.1. Macro-Economic Factors
3.1.1. Involvement of governments and private organizations in ophthalmic care
3.1.2. Increasing consumer awareness
3.1.3. Agreement with distributers to increase product reach
3.2. Opportunity Analysis
3.3. Pipeline Snapshot and Research Grants
3.4. Reimbursement Scenario
4. North America Dry Eye Syndrome Treatment Market Analysis
4.1. Key Regulations
4.2. PESTLE Analysis
4.3. Porter’s Analysis
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Trends
4.5. Introduction
4.5.1. Point Share (BPS) Analysis By Country
4.5.2. Y-o-Y Growth Projections By Country
4.6. Historical Market Size (US$ Mn) Analysis 2012-2016, By Country
4.6.1. U.S.
4.6.2. Canada
4.7. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Country
4.7.1. U.S.
4.7.2. Canada
4.8. Historical Market Size (US$ Mn) Analysis 2012-2016, By Product Type
4.8.1. Cyclosporine
4.8.2. Topical Corticosteroids
4.8.3. Artificial Tears
4.8.4. Punctal Plugs
4.8.4.1. Dissolvable
4.8.4.2. Removable
4.8.5. Oral Omega Supplements
4.8.6. Others
4.9. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Product Type
4.9.1. Cyclosporine
4.9.2. Topical Corticosteroids
4.9.3. Artificial Tears
4.9.4. Punctal Plugs
4.9.4.1. Dissolvable
4.9.4.2. Removable
4.9.5. Oral Omega Supplements
4.9.6. Others
4.10. Historical Market Size (US$ Mn) Analysis 2012-2016, By Distribution Channel
4.10.1. Hospital Pharmacies
4.10.2. Eye Health Clinics
4.10.3. Retail Pharmacies
4.10.4. Online Pharmacies
4.11. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Distribution Channel
4.11.1. Hospital Pharmacies
4.11.2. Eye Health Clinics
4.11.3. Retail Pharmacies
4.11.4. Online Pharmacies
4.12. Key Representative Market Participants (Intensity Map)
5. Western Europe Automotive Filter Market Analysis
5.1. Key Regulations
5.2. PESTLE Analysis
5.3. Porter’s Analysis
5.4. Market Dynamics
5.4.1. Drivers
5.4.2. Restraints
5.4.3. Trends
5.5. Introduction
5.5.1. Point Share (BPS) Analysis By Country
5.5.2. Y-o-Y Growth Projections By Country
5.6. Historical Market Size (US$ Mn) Analysis 2012-2016, By Country
5.6.1. Germany
5.6.2. France
5.6.3. U.K.
5.6.4. Italy
5.6.5. Spain
5.6.6. Rest of Western Europe
5.7. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Country
5.7.1. Germany
5.7.2. France
5.7.3. U.K.
5.7.4. Italy
5.7.5. Spain
5.7.6. Rest of Western Europe
5.8. Historical Market Size (US$ Mn) Analysis 2012-2016, By Product Type
5.8.1. Cyclosporine
5.8.2. Topical Corticosteroids
5.8.3. Artificial Tears
5.8.4. Punctal Plugs
5.8.5. Oral Omega Supplements
5.8.6. Others
5.9. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Product Type
5.9.1. Cyclosporine
5.9.2. Topical Corticosteroids
5.9.3. Artificial Tears
5.9.4. Punctal Plugs
5.9.5. Oral Omega Supplements
5.9.6. Others
5.10. Historical Market Size (US$ Mn) Analysis 2012-2016, By Distribution Channel
5.10.1. Hospital Pharmacies
5.10.2. Eye Health Clinics
5.10.3. Retail Pharmacies
5.10.4. Online Pharmacies
5.11. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Distribution Channel
5.11.1. Hospital Pharmacies
5.11.2. Eye Health Clinics
5.11.3. Retail Pharmacies
5.11.4. Online Pharmacies
5.12. Key Representative Market Participants (Intensity Map)
6. Eastern Europe Motorcycle Filter Market Analysis
6.1. Key Regulations
6.2. PESTLE Analysis
6.3. Porter’s Analysis
6.4. Market Dynamics
6.4.1. Drivers
6.4.2. Restraints
6.4.3. Trends
6.5. Introduction
6.5.1. Point Share (BPS) Analysis By Country
6.5.2. Y-o-Y Growth Projections By Country
6.6. Historical Market Size (US$ Mn) Analysis 2012-2016, By Country
6.6.1. Russia
6.6.2. Poland
6.6.3. Rest of Europe
6.7. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Country
6.7.1. Russia
6.7.2. Poland
6.7.3. Rest of Europe
6.8. Historical Market Size (US$ Mn) Analysis 2012-2016, By Product Type
6.8.1. Cyclosporine
6.8.2. Topical Corticosteroids
6.8.3. Artificial Tears
6.8.4. Punctal Plugs
6.8.5. Oral Omega Supplements
6.8.6. Others
6.9. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Product Type
6.9.1. Cyclosporine
6.9.2. Topical Corticosteroids
6.9.3. Artificial Tears
6.9.4. Punctal Plugs
6.9.5. Oral Omega Supplements
6.9.6. Others
6.10. Historical Market Size (US$ Mn) Analysis 2012-2016, By Distribution Channel
6.10.1. Hospital Pharmacies
6.10.2. Eye Health Clinics
6.10.3. Retail Pharmacies
6.10.4. Online Pharmacies
6.11. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Distribution Channel
6.11.1. Hospital Pharmacies
6.11.2. Eye Health Clinics
6.11.3. Retail Pharmacies
6.11.4. Online Pharmacies
6.12. Key Representative Market Participants (Intensity Map)
7. Asia Pacific Excluding Japan (APEJ) Automotive Filter Market Analysis
7.1. Key Regulations
7.2. PESTLE Analysis
7.3. Porter’s Analysis
7.4. Market Dynamics
7.4.1. Drivers
7.4.2. Restraints
7.4.3. Trends
7.5. Introduction
7.5.1. Point Share (BPS) Analysis By Country
7.5.2. Y-o-Y Growth Projections By Country
7.6. Historical Market Size (US$ Mn) Analysis and 2012-2016, By Country
7.6.1. China
7.6.2. India
7.6.3. Australia and New Zealand
7.6.4. ASEAN
7.6.5. Rest of APAC
7.7. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Country
7.7.1. China
7.7.2. India
7.7.3. Australia and New Zealand
7.7.4. ASEAN
7.7.5. Rest of APAC
7.8. Historical Market Size (US$ Mn) Analysis 2012-2016, By Product Type
7.8.1. Cyclosporine
7.8.2. Topical Corticosteroids
7.8.3. Artificial Tears
7.8.4. Punctal Plugs
7.8.5. Oral Omega Supplements
7.8.6. Others
7.9. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Product Type
7.9.1. Cyclosporine
7.9.2. Topical Corticosteroids
7.9.3. Artificial Tears
7.9.4. Punctal Plugs
7.9.5. Oral Omega Supplements
7.9.6. Others
7.10. Historical Market Size (US$ Mn) Analysis 2012-2016, By Distribution Channel
7.10.1. Hospital Pharmacies
7.10.2. Eye Health Clinics
7.10.3. Retail Pharmacies
7.10.4. Online Pharmacies
7.11. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Distribution Channel
7.11.1. Hospital Pharmacies
7.11.2. Eye Health Clinics
7.11.3. Retail Pharmacies
7.11.4. Online Pharmacies
7.12. Key Representative Market Participants (Intensity Map)
8. Japan Motorcycle Filter Market Analysis
8.1. Key Regulations
8.2. PESTLE Analysis
8.3. Porter’s Analysis
8.4. Market Dynamics
8.4.1. Drivers
8.4.2. Restraints
8.4.3. Trends
8.5. Introduction
8.5.1. Point Share (BPS) Analysis By Country
8.5.2. Y-o-Y Growth Projections By Country
8.6. Historical Market Size (US$ Mn) Analysis 2012-2016, Japan
8.7. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, Japan
8.8. Historical Market Size (US$ Mn) Analysis 2012-2016, By Product Type
8.8.1. Cyclosporine
8.8.2. Topical Corticosteroids
8.8.3. Artificial Tears
8.8.4. Punctal Plugs
8.8.5. Oral Omega Supplements
8.8.6. Others
8.9. Current Market Size (US$ Mn) Analysis Forecast 2017-2027, By Product Type
8.9.1. Cyclosporine
8.9.2. Topical Corticosteroids
8.9.3. Artificial Tears
8.9.4. Punctal Plugs
8.9.5. Oral Omega Supplements
8.9.6. Others
8.10. Historical Market Size (US$ Mn) Analysis 2012-2016, By Distribution Channel
8.10.1. Hospital Pharmacies
8.10.2. Eye Health Clinics
8.10.3. Retail Pharmacies
8.10.4. Online Pharmacies
8.11. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Distribution Channel
8.11.1. Hospital Pharmacies
8.11.2. Eye Health Clinics
8.11.3. Retail Pharmacies
8.11.4. Online Pharmacies
8.12. Key Representative Market Participants (Intensity Map)
9. Latin America Motorcycle Filter Market Analysis
9.1. Key Regulations
9.2. PESTLE Analysis
9.3. Porter’s Analysis
9.4. Market Dynamics
9.4.1. Drivers
9.4.2. Restraints
9.4.3. Trends
9.5. Introduction
9.5.1. Point Share (BPS) Analysis By Country
9.5.2. Y-o-Y Growth Projections By Country
9.6. Historical Market Size (US$ Mn) Analysis 2012-2016, By Country
9.6.1. Brazil
9.6.2. Mexico
9.6.3. Rest of Latin America
9.7. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Country
9.7.1. Brazil
9.7.2. Mexico
9.7.3. Rest of Latin America
9.8. Historical Market Size (US$ Mn) Analysis 2012-2016, By Product Type
9.8.1. Cyclosporine
9.8.2. Topical Corticosteroids
9.8.3. Artificial Tears
9.8.4. Punctal Plugs
9.8.5. Oral Omega Supplements
9.8.6. Others
9.9. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Product Type
9.9.1. Cyclosporine
9.9.2. Topical Corticosteroids
9.9.3. Artificial Tears
9.9.4. Punctal Plugs
9.9.5. Oral Omega Supplements
9.9.6. Others
9.10. Historical Market Size (US$ Mn) Analysis 2012-2016, By Distribution Channel
9.10.1. Hospital Pharmacies
9.10.2. Eye Health Clinics
9.10.3. Retail Pharmacies
9.10.4. Online Pharmacies
9.11. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Distribution Channel
9.11.1. Hospital Pharmacies
9.11.2. Eye Health Clinics
9.11.3. Retail Pharmacies
9.11.4. Online Pharmacies
9.12. Key Representative Market Participants (Intensity Map)
10. Middle East & Africa Automotive Filter Market Analysis
10.1. Key Regulations
10.2. PESTLE Analysis
10.3. Porter’s Analysis
10.4. Market Dynamics
10.4.1. Drivers
10.4.2. Restraints
10.4.3. Trends
10.5. Introduction
10.5.1. Point Share (BPS) Analysis By Country
10.5.2. Y-o-Y Growth Projections By Country
10.6. Historical Market Size (US$ Mn) Analysis 2012-2016, By Country
10.6.1. Brazil
10.6.2. Mexico
10.6.3. Rest of Latin America
10.7. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Country
10.7.1. Brazil
10.7.2. Mexico
10.7.3. Rest of Latin America
10.8. Historical Market Size (US$ Mn) Analysis 2012-2016, By Product Type
10.8.1. Cyclosporine
10.8.2. Topical Corticosteroids
10.8.3. Artificial Tears
10.8.4. Punctal Plugs
10.8.5. Oral Omega Supplements
10.8.6. Others
10.9. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Product Type
10.9.1. Cyclosporine
10.9.2. Topical Corticosteroids
10.9.3. Artificial Tears
10.9.4. Punctal Plugs
10.9.5. Oral Omega Supplements
10.9.6. Others
10.10. Historical Market Size (US$ Mn) Analysis 2012-2016, By Distribution Channel
10.10.1. Hospital Pharmacies
10.10.2. Eye Health Clinics
10.10.3. Retail Pharmacies
10.10.4. Online Pharmacies
10.11. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Distribution Channel
10.11.1. Hospital Pharmacies
10.11.2. Eye Health Clinics
10.11.3. Retail Pharmacies
10.11.4. Online Pharmacies
10.12. Key Representative Market Participants (Intensity Map)
11. Competition Landscape
11.1. Competition Dashboard
11.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
11.2.1. Allergan Plc
11.2.2. Novartis AG
11.2.3. Otsuka Pharmaceutical Co.,Ltd.
11.2.4. Shire Plc
11.2.5. Santen Pharmaceutical Co Ltd
11.2.6. Valent Pharmaceuticals
11.2.7. Akorn, Inc
11.2.8. Abbott Laboratories
11.2.9. Thea Pharmaceuticals Limited
11.2.10. OASIS Medical
11.2.11. Altaire Pharmaceuticals Inc
11.2.12. Boiron USA
11.2.13. Similasan Corporation
11.2.14. Scope Ophthalmics Ltd.
11.2.15. Reckitt Benckiser Group PLC
11.2.16. Medicom Healthcare Ltd
11.2.17. FDC Limited
11.2.18. Lupin Limited
11.2.19. Jamjoom Pharmaceuticals Co.
11.2.20. Sentiss Pharma Private limited
12. Global Automotive Filter Market Analysis, By Region
12.1. Pricing Analysis
12.2. Introduction
12.2.1. Point Share (BPS) Analysis By Country
12.2.2. Y-o-Y Growth Projections By Country
12.3. Historical Market Size (US$ Mn) Analysis 2012-2016, By Region
12.3.1. North America
12.3.2. Western Europe
12.3.3. Western Europe
12.3.4. Asia Pacific Except Japan (APEJ)
12.3.5. Japan
12.3.6. Latin America
12.3.7. Middle East and Africa
12.4. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Region
12.4.1. North America
12.4.2. Western Europe
12.4.3. Western Europe
12.4.4. Asia Pacific Except Japan (APEJ)
12.4.5. Japan
12.4.6. Latin America
12.4.7. Middle East and Africa
12.5. Forecast Factors: Relevance and Impact
12.6. Key Representative Market Participants (Intensity Map)
13. Global Automotive Filter Market Analysis, By Product Type
13.1. Historical Market Size (US$ Mn) Analysis 2012-2016, By Product Type
13.1.1. Cyclosporine
13.1.2. Topical Corticosteroids
13.1.3. Artificial Tears
13.1.4. Punctal Plugs
13.1.5. Oral Omega Supplements
13.1.6. Others
13.2. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Product Type
13.2.1. Cyclosporine
13.2.2. Topical Corticosteroids
13.2.3. Artificial Tears
13.2.4. Punctal Plugs
13.2.5. Oral Omega Supplements
13.2.6. Others
14. Global Automotive Filter Market Analysis and Forecast By Distribution Channel
14.1. Historical Market Size (US$ Mn) Analysis 2012-2016, By Distribution Channel
14.1.1. Hospital Pharmacies
14.1.2. Eye Health Clinics
14.1.3. Retail Pharmacies
14.1.4. Online Pharmacies
14.2. Current Market Size (US$ Mn) Analysis and Forecast 2017-2027, By Distribution Channel
14.2.1. Hospital Pharmacies
14.2.2. Eye Health Clinics
14.2.3. Retail Pharmacies
14.2.4. Online Pharmacies
14.3. Market Attractiveness Analysis
14.3.1. By Region
14.3.2. By Product Type
14.3.3. By Distribution Channel

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report